Illumina to Webcast Live Presentation at the Morgan Stanley Global
Morgan Stanley Global Healthcare Conference 2013
SAN DIEGO -- August 27, 2013
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the
Company’s presentation at the Morgan Stanley Global Healthcare Conference in
New York on September 10, 2013. The live webcast is scheduled to begin at 1:30
PM EDT and will feature a brief overview of the company by Jay Flatley,
President and Chief Executive Officer, followed by a question and answer
The webcast can be accessed in the Investor Relations section of Illumina's
web site under the "Company" tab at www.illumina.com.
Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer
of life science tools and integrated systems for the analysis of genetic
variation and function. We provide innovative sequencing and array-based
solutions for genotyping, copy number variation analysis, methylation studies,
gene expression profiling, and low-multiplex analysis of DNA, RNA, and
protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products accelerate
genetic analysis research and its application, paving the way for molecular
medicine and ultimately transforming healthcare.
Rebecca Chambers, 858-255-5243
Jennifer Temple, 858-882-6822
Press spacebar to pause and continue. Press esc to stop.